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Ballester BR, Maier M, Duff A, Cameirão M, Bermúdez S,
Duarte E, Cuxart A, Rodríguez S, San Segundo Mozo RM,
Verschure PF. A critical time window for recovery extends beyond
one-year post-stroke. J Neurophysiol 122: 350–357, 2019. First pub-
lished May 29, 2019; doi:10.1152/jn.00762.2018.—The impact of
rehabilitation on post-stroke motor recovery and its dependency on
the patient’s chronicity remain unclear. The field has widely accepted
the notion of a proportional recovery rule with a “critical window for
recovery” within the first 3–6 mo poststroke. This hypothesis justifies
the general cessation of physical therapy at chronic stages. How-
ever, the limits of this critical window have, so far, been poorly
defined. In this analysis, we address this question, and we further
explore the temporal structure of motor recovery using individual
patient data from a homogeneous sample of 219 individuals with mild
to moderate upper-limb hemiparesis. We observed that improvement
in body function and structure was possible even at late chronic
stages. A bootstrapping analysis revealed a gradient of enhanced
sensitivity to treatment that extended beyond 12 mo poststroke.
Clinical guidelines for rehabilitation should be revised in the context
of this temporal structure.
NEW & NOTEWORTHY Previous studies in humans suggest that
there is a 3- to 6-mo “critical window” of heightened neuroplasticity
poststroke. We analyze the temporal structure of recovery in patients
with hemiparesis and uncover a precise gradient of enhanced sensi-
tivity to treatment that expands far beyond the limits of the so-called
critical window. These findings highlight the need for providing
therapy to patients at the chronic and late chronic stages.
motor recovery; neuroplasticity; neurorehabilitation; stroke recovery;
virtual reality
INTRODUCTION
The absolute incidence of stroke will continue to rise glob-
ally with a predicted 12 million stroke deaths in 2030 and 60
million stroke survivors worldwide (Eilers 2003). Stroke leads
to focal lesions in the brain due to cell death following hypoxia
and inflammation, affecting both gray and white matter tracts
(Corbetta et al. 2015). After a stroke, a wide range of deficits
can occur with varying onset latencies such as hemiparesis,
abnormal posture, spatial hemineglect, aphasia, and spasticity,
along with affective and cognitive deficits, chronic pain, and
depression (Teasell et al. 2003). Due to improved treatment
procedures during the acute stage of stroke (e.g., thrombolysis
and thrombectomy), the associated reduction in stroke mortal-
ity has led to a greater proportion of patients facing impair-
ments and needing long-term care and rehabilitation. However,
prevention, diagnostics, rehabilitation, and prognostics of
stroke recovery have not kept pace (Veerbeek et al. 2014).
Motor recovery after stroke has been widely operationalized
as the individual’s change in two domains: 1) body function
and structure (WHO 2001), whose improvement has been
called “true recovery” (Bernhardt et al. 2017) and refers to the
restitution of a movement repertoire that the individual had
before the injury; and 2) the ability to successfully perform the
activities of daily living (Levin et al. 2009). While the former
is mainly due to the interaction of poststroke plasticity mech-
anisms and sensorimotor training, the latter is also influenced
by the use of explicit and implicit compensatory strategies
(Bernhardt et al. 2017; Kwakkel et al. 2017). The most ac-
cepted measure for recovery of body function and structure is
the change in the Fugl-Meyer Assessment of the upper extrem-
ity (UE-FM) scores (Kwakkel et al. 2017), while other clinical
scales focus on the assessment of activities, such as the Che-
doke Arm and Hand Activity Inventory (CAHAI) (Barreca et
al. 2005) or the Barthel Index for Activities of Daily Living
(BI) (Granger et al. 1979).
Poststroke motor recovery mostly follows a nonlinear tra-
jectory that reaches asymptotic levels a few months after the
injury (Kwakkel et al. 2004). This model suggests the existence
of a period of heightened plasticity in which the patient seems
to be more responsive to treatment, the so-called “critical
window” for recovery. Aiming at characterizing the temporal
structure of recovery, animal models and clinical research have
identified a combination of mechanisms underlying neurolog-
ical repair that seems to be unique to the injured brain,
including neurogenesis, gliogenesis, axonal sprouting, and the
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rebalancing of excitation and inhibition in cortical networks
(Ward 2017). This state of enhanced plasticity seems to be
transient and interacts closely with sensorimotor training to
facilitate the recovery of motor function (Zeiler et al. 2016).
However, there is no clear evidence of the exact temporal
structure of enhanced responsiveness to treatment in humans,
and as a result the optimal timing and intensity of treatment
remain unclear. A systematic review of 14 studies suggested
that, on average, recovery reaches a plateau at 15 wk poststroke
for patients with severe hemiparesis and at 6.5 wk for patients
with mild hemiparesis (Hendricks et al. 2002). This study
however failed to conduct a meta-analysis due to substantial
heterogeneity of the sample and protocols. Currently, an on-
going clinical trial is investigating the existence and the dura-
tion of a critical window of enhanced neuroplasticity in hu-
mans following ischemic stroke (McDonnell et al. 2015).
Based on the assumption of the existence of this critical period,
the SMARTS 2 trial (NCT02292251) (Krakauer and Cortés
2018) is currently investigating the effect of early and intensive
therapy on upper extremity motor recovery. Sharing the same
research question, the Critical Periods After Stroke Study
(CPASS) is a large ongoing randomized controlled trial that
focuses on determining the optimal time after stroke for inten-
sive motor training (Dromerick et al. 2015). To contribute to
the delineation of a temporal structure of stroke recovery in
humans, we performed an analysis of individual patient clinical
data from 219 subjects with upper-limb hemiparesis, who
followed occupational therapy (OT) or a virtual reality (VR)-
based training protocol using the Rehabilitation Gaming Sys-
tem (RGS) (Cameirão et al. 2010) (Fig. S1 in Supplemental
Material; all Supplemental material is available at https://
doi.org/10.5281/zenodo.3246368). We show that physical
therapy has a significant impact on the function of the upper
extremity (UE) at all periods poststroke considered, uncover-
ing a gradient of responsiveness to treatment that extends 12
mo poststroke.
MATERIALS AND METHODS
Data sets. In this analysis, we included individual patient data from
a set of protocols for the recovery of upper extremity function. These
protocols included interventions combining OT and a specific VR
training protocol (RGS) (Section 1 in Supplemental Material). Partic-
ipants met the following inclusion criteria: 1) ischemic strokes (mid-
dle cerebral artery territory) or hemorrhagic strokes (intracerebral); 2)
mild-to-moderate upper limb hemiparesis (Medical Research Council
scale for proximal muscles 2) after a first-ever stroke; 3) age
between 45 and 85 yr old; and 4) the absence of any significant
cognitive impairment (Mini-Mental State Evaluation 22). All re-
search on human subjects reported in this manuscript was prospec-
tively approved by the Institutional Review Board of Hospital Joan
XXIII, Hospital Vall d’Hebron and Hospital del Mar i l’Esperança
from Catalonia, and all participants provided written informed
consent.
The data sets were divided into 17 conditions depending on the
specific characteristics of the patients and the requirements of the
treatment provided (Table 1). Most of the RGS conditions included in
this analysis have an identical design based on the same set of
neurorehabilitation principles (Maier et al. 2019) (see Supplemental
Material for a full description of the system and its mechanisms).
However, two relevant design differences should be noticed. First, in
two protocols used with acute patients the dosage was three days a
week instead of five (conditions 5 and 6 in Table 1). Second, in one
study the implicit feedback is augmented through haptic actuators
(condition 14 in Table 1, RGS Haptics).
Furthermore, all RGS protocols used by acute and subacute patients
combined RGS-based training with supervised OT, while condition 13
tested the application of RGS in a domiciliary setting. Despite these
differences, in all RGS conditions the same protocol was used. A
formal risk of bias analysis on the primary outcome (i.e., change in the
UE-FM) was performed using ROBINS-I tool (Table S1 in Supple-
mental Material) covering the evaluation of confounding variables,
recruitment for participants, intervention classification, deviations
from intended interventions, missing data, measurement of outcomes,
and selection of reported results.
Outcome measures. The primary outcome considered in this anal-
ysis was the UE motor impairment and activity at the end of therapy,
as measured by two standardized clinical scales: the UE-FM and
CAHAI (Barreca et al. 2005) scales. Previous studies have shown that
the UE-FM shows excellent reliability, responsiveness, and validity
properties (Wei et al. 2011). Second, the CAHAI evaluates the UE
bilateral function in the performance of specific iADLs (Barreca et al.
2005). Score changes in the UE-FM and CAHAI were used as
measures of motor improvement (body function and structure) and
performance in Instrumental Activities of Daily Living (iADLs),
respectively. In addition, the BI (Granger et al. 1979) was considered
a secondary outcome for the assessment of the patient’s level of
independence.
Statistical analysis. We performed two analyses. First, we explored
recovery measures independently within each of the 17 conditions. In
this analysis, we examined recovery measures using the UE-FM and
CAHAI in absolute terms. Here, we quantified improvement using
mean differences and 95% confidence intervals (CI). Second, we
analyzed the temporal structure of recovery poststroke by merging all
the conditions (178 patients performing RGS-based training and 368
follow-up measures) and bootstrapping our data using the Efron and
Tib method (Efron and Tibshirani 1986) to evaluate the effects of the
therapy across the patients’ chronicity (subacute, early chronic, and
late chronic). This method overcomes the high intersubject variability
and provides a superior statistical power (Duff et al. 2011). The
homogenized data were generated by separating improvement mea-
sures at different time intervals and allocating them to either being an
RGS-based training, OT based-training, or follow-up (i.e., no ther-
apy). We then calculated the improvement rate per week normalized
within subjects according to their respective recovery potential. This
metric therefore captures the improvement observed normalized to the
total amount that each patient can gain given the baseline of each in
standardized clinical scales. The normalized improvement (NI) on
scale i at time t was defined as:
NIi, t   Xit  Xit  0MAxScorei  Xit  0  100 (1)
where Xi (t  0) refers to the corresponding baseline score. According
to this normalization method, a patient with a baseline score of 16 in
UE-FM will have 50 points of potential improvement since the
UE-FM has a maximum score of 66 (da Silva Cameirão et al. 2011).
In case this patient would recover 10 points, reaching a score of 26
points in the scale at T1, this would be equal to 20% (i.e., 10/50) of
NI. Note that this value may depend on the time lapsed between
baseline measurement and subsequent assessments. We overcome this
bias by dividing the NI by the number of weeks between both
measurement time points, therefore obtaining an estimate of NI per
week. This normalization method allowed us to bundle the data of the
different conditions while overcoming the risk of bias due to the
variation in treatment intensity and response rates among protocols
(Laver et al. 2015; Makuch and Johnson 1989; Saposnik and Levin
2011). We computed a NI value for two time intervals: postassess-
ment and long-term follow-up. For example, for a patient who
followed RGS training with a baseline, end of the treatment, and
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follow-up assessment, we calculated the NI per week for two periods:
baseline to end of the treatment and end of the treatment to long-term
follow-up. The measured change from baseline to the end of the
treatment was allocated to the RGS or the OT group, while the change
from the end of the treatment to follow-up was assigned to the
follow-up group. If a patient had multiple follow-up assessments at
different time points, all the follow-up measures were assigned to the
follow-up group.
For all tests, statistical significance levels were set at P  0.05.
Average and dispersion values are reported in medians  median
absolute deviation (MAD) or means  SD according to results
from normality assessments (Kolmogorov-Smirnov normality
test). To facilitate the exploration and replication of our findings,
we published the complete data set and analysis source code as
freely available and open, accessible at https://doi.org/10.5281/
zenodo.3246368.
RESULTS
Impact assessment of individual conditions. The complete
data set includes 219 stroke survivors assigned to 17 rehabil-
itation conditions (Table 1) at different stages post-stroke:
acute (3 wk), subacute (3 wk–6 mo), early chronic (6–18
mo), and late chronic (18 mo). We observed significant gains
in body function and structure after treatment, both in acute
(median 20.0  7.9 MAD, P  0.01) and subacute patients
(median 8.0  5.6 MAD, P  0.01), as measured by UE-FM
(Fig. 1A; Table S1 in Supplemental Material). These gains
were accompanied by an improved performance in iADLs in
both acute (median 42.5  14.1 MAD, P  0.01) and subacute
groups (median 7.0  10.5 MAD, P  0.01) (Fig. 1B; Table
S2 in Supplemental Material). More interestingly, at the
Table 1. Overview of therapy conditions
ID Group
Average
Chronicity Intervention N Mean Age (SD) TSO (SD) HA (%left) Sex (%men) Oxf. Class. References
Acute stage
1 Control Acute 12w;5d/w;20min 5 69 (19) 9 (15) 40 80 2/1/0/1/1 (Duff et al. 2013)
2 RGS Acute 3w;5d/w;20min 5 70 (22) 11 (4) 60 20 1/2/0/1/1 (Duff et al. 2013;
Rodriguez et al.
2011)
3 RGS Acute 12w;3d/w;20min 10 63.5 (29) 11 (17) 40 30 2/2/2/3/1 (da Silva Cameirão
et al. 2011; Duff
et al. 2013)
4 Control Acute 3w;5d/w;20min 5 64 (16) 13 (5) 60 60 2/2/0/0/1 (Duff et al. 2013;
Rodriguez et al.
2011)
5 Control Acute 12w;3d/w;20min;
NSG
4 65 (28) 13 (12) 75 50 1/0/1/1/1 (da Silva Cameirão
et al. 2011)
6 Control Acute 12w;3d/w;20min;
IOT
5 56 (27) 15 (11) 40 40 1/1/2/0/1 (da Silva Cameirão
et al. 2011)
Subacute stage
7 RGS Subacute 3w;5d/w;20min 49 61 (43) 70 (375) 30.6 30.6 11/9/13/1/15 (See Supplemental
Material)
8 Control Subacute 3w;5d/w;20min 4 57 (17) 90 (226) 0 50 4/0/0/0/0 (See Supplemental
Material)
Early chronic stage
9 RGS Chronic 6w;5d/w;30min;
AM
9 63 (31) 400 (5,805) 33.3 33.3 (Ballester et al.
2016)
10 RGS Chronic 6w;5d/w;30min 9 57 (36) 735 (4,471) 11.1 55.6 (Ballester et al.
2016)
11 Control Chronic 3w;5d/w;20min;
domiciliary
18 68.5 (40) 751 (1,536) 33.3 50 6/2/4/0/6 (Ballester et al.
2017; Nirme et al.
2013)
12 RGS Chronic 3w;5d/w;20min;
OT
20 64.5 (37) 770 (2,789) 40 30 7/0/4/0/9 (Duff et al. 2013)
Late chronic stage
13 RGS Late Chronic 3w;5d/w;20min;
domiciliary
17 61.5 (43) 997 (2,987) 47.1 35.3 4/3/4/0/6 (Ballester et al.
2017; Nirme et al.
2013)
14 RGS Late Chronic 4w;5d/w;30min;
haptics
14 63 (45) 1,051 (3,250) 50 57.1 6/0/4/1/3 (Cameirão et al.
2012)
15 RGS Late Chronic 3w;5d/w;30min 15 58 (60) 1,261 (2,041) 33.3 46.7 0/1/2/0/12 (Duff et al. 2013)
16 RGS Late Chronic 4w;5d/w;30min 16 69.5 (46) 1,536 (3,891) 43.8 62.5 6/4/5/0/1 (Cameirão et al.
2012)
17 RGS Late Chronic 4w;5d/w;30min;
exoskeleton
14 60 (32) 1,758 (2,880) 35.7 71.4 3/1/4/1/5 (Cameirão et al.
2012)
Intervention: duration of included protocols indicated per number of weeks (w), days per week (d/w), and minutes (min) of occupational therapy (OT) and
virtual reality (VR)-based therapy per day. AM, condition including the amplification of movements in VR; HA, percentage of patients with left hemisphere
affected; Haptics, condition including delivery of haptic feedback during training; IOT, condition including intensive occupational therapy; N, sample size in the
experimental group; NSG, protocol based on nonspecific gaming system (i.e., Nintendo Wii); Oxf. Class., count of stroke types [lacunar stroke (LACS)/partial
anterior circulation stroke (PACS)/total anterior circulation stroke (TACS)/or posterior circulation stroke (POCS)] according to the Oxford Stroke Classification
scale; RGS, Rehabilitation Gaming System; Sex, percentage of men; TSO, median (maximum  minimum) days since the stroke.
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chronic and late chronic stage, the therapy showed overall
effectiveness in facilitating improvements in UE-FM (ranging
from median 2.7  3.8 MAD to median 7.0  3.6 MAD, P 
0.05) and CAHAI (median 1.0  3.8 MAD to median
8.0  5.6 MAD, P  0.05). The application of the RGS at
home showed no significant effects in UE-FM but induced
statistically significant gains in the execution of iADLs (me-
dian 1.0  1.6 MAD, P  0.01). Surprisingly, a dosage-
matched RGS study conducted in the clinic on late chronic
patients had an impact on UE-FM (condition 15 in Table 1,
median 3.0  4.1 MAD, P  0.01; Fig. 1, A and B, condition
Late Chronic 3w). Furthermore, we observed a clear depen-
dency between the number of days post-stroke before the start
of the RGS therapy and the improvements in motor function as
measured by UE-FM and CAHAI (P  0.001, Spearman
correlation).
The analysis of follow-up measures illustrates that improve-
ments were retained in all groups. The subacute group training
with RGS exhibited a significant improvement during the
follow-up period (3 mo after the end of treatment) both in
UE-FM (median 2.0  5.3 MAD, P  0.01) and CAHAI
(median 3.0  11.7 MAD, P  0.01) (Fig. S3, A and B, in
Supplemental Material). The acute groups, however, showed
higher interindividual variability and nonsignificant gains from
the end of the therapy to the follow-up.
Revealing an extended critical window for recovery. To
study the temporal structure of recovery after a stroke, we now
combined the impact of all the conditions and examined the
effects of chronicity on the patients’ normalized improvement
(NI; see Eq. 1 in MATERIALS AND METHODS). In the group
receiving therapy (RGS), we observed a mean UE-FM NI per
week of 5.2  1.0 SD % in subacute (median 10.3 wk) and
2.7  0.6 and 1.4  0.3 SD % in early chronic (median 12.0
mo) and late chronic (median 3.9 yr) patients, respectively
(Fig. 2, top left). The change on the CAHAI scale shows a
mean NI per week of 3.4  0.7 SD % in subacute, and
1.9  0.4 and 1.1  0.2 SD % in early and late chronic
patients, respectively (Fig. 2, bottom left). We found statisti-
cally significant differences between subacute and early
chronic patients, even during the follow-up period (P  0.01,
Wilcoxon Rank-Sum). Those patients at the subacute phase
showed higher NI per week. However, only in the RGS group,
the early chronic group (6–18 mo) showed higher recovery
rates than the late chronic group (18 mo) (P  0.05, Wil-
coxon Rank-Sum). This analysis reveals a long-lasting gradient
of sensitivity to treatment that remains visible across the first
18 mo post-stroke (Fig. 2, right). This effect was not present in
the follow-up measures, a period in which no therapy was
administered. Due to the low number of chronic patients in the
OT group, we could not apply the bootstrapping method to this
sample for comparison. Despite this, we display the full data to
allow for visual inspection.
The patient’s age could not explain the gradient of sensitiv-
ity to treatment found in the RGS group even at early and late
chronic stages (Spearman’s correlation r  0.003, P  0.96)
and neither by the patient’s baseline impairment score (Spear-
man’s correlation r  0.052, P  0.43 for FM; r  0.006, P 
0.93 for CAHAI). Notice that the design of this analysis
controls for additional confounding variables since all patients
were recruited according to standard inclusion and exclusion
criteria concerning age, motor impairment severity, cognitive
impairment severity, type of stroke (Oxford Classification),
hand dominance, the absence of a second stroke, and gender.
None of these variables correlate with the patients’ chronicity,
and therefore none of them can explain the uncovered gradient.
The homogeneity of the demographics of these patients in
combination with highly heterogeneous chronicity highlights
the peculiarity of this data sample.
Finally, we analyzed the covariation of the recovery mea-
sures of the different clinical scales. We observed a distinct
effect of the patient’s chronicity on the association of UE-
FM, CAHAI, and BI scores. While at the acute/subacute
stages these recovery measures correlate, they do progressively
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Fig. 1. Effect of Rehabilitation Gaming System (RGS)-based treatment from the start (baseline) to the end of the treatment (T1). Impact measured on upper limb
motor function in the Upper Extremity section of the Fugl-Meyer scale (UE-FM; top) and performance in Instrumental Activities of Daily Living (iADLs)
captured by the Chedoke Arm and Hand Activity Inventory (CAHAI; bottom). The effect represents a change in each scale from the start to the end of the
treatment. Notice that the horizontal axis refers to the RGS conditions listed in Table 1 and follows the same order. Shaded areas indicate the data distribution
color coded according to the chronicity of stroke patients participating in each rehabilitation condition: acute (green), subacute (orange), early (blue), and late
(purple) chronic stage. *P  0.05, **P  0.01.
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dissociate as the patient advances toward the late chronic stage
(Fig. 3).
DISCUSSION
In opposition to compensation, recovery of body function
and structure (Levin et al. 2009) [i.e., “true recovery” accord-
ing to (Bernhardt et al. 2017)] refers to the partial or complete
restoration of the repertoire of behaviors that was available
before injury (Bernhardt et al. 2017; Zeiler and Krakauer
2013). In the absence of a precise assessment of kinematic
and kinetic measures, recovery of body function and struc-
ture has been operationalized as the change in UE-FM
scores (Kwakkel et al. 2017). Previous studies on humans
have identified a 3- to 6-mo period of enhanced neuroplas-
ticity mechanisms triggered by the injury (Hendricks et al.
2002; Kitago and Krakauer 2013). Here, by analyzing clin-
ical recovery scores from stroke patients with variable chro-
nicity but comparable baseline impairment levels, we are able
to detect a smooth decrease in the sensitivity to treatment (i.e.,
critical window for recovery) that extends beyond 12 mo
post-stroke. These results suggest that there is a long-lasting
critical period of enhanced neuroplasticity post-stroke that
enables improvement in body function and structure even at
late chronic stages. This is the first time that such an extended
critical period of recovery is reported. Capturing this effect
may require large homogeneous data sets and analytic methods
with enhanced accuracy such as the bootstrapping technique
we apply here.
In line with the previous literature, our data illustrate the
correlation of UE-FM with CAHAI and BI scores at acute
stages (Beebe and Lang 2009; Rabadi and Rabadi 2006).
However, we found that at chronic stages these scales disso-
ciate, possibly due to the introduction of compensatory mech-
anisms (Rabadi and Rabadi 2006). Altogether, our data support
the interpretation of UE-FM as an assessment of recovery of
body function and structure that is independent of improve-
ment in the performance of iADLs and closely associated with
true neurological repair (Kwakkel et al. 2004).
The results presented in this study do require further inves-
tigation for a number of reasons. The clinical importance of the
detected improvements is marginal at late chronic stages. It is
relevant to notice, however, that the UE-FM minimal clinically
important difference (MCID) is derived from the chronicity-
dependent variability in the UE-FM’s measurement error and
the patient’s perceived improvement thresholds (Page et al.
2012). According to previous studies, the UE-FM MCID
ranges from 16 to 30% of the scale’s maximum value at acute
stages (30 days post-stroke) (Lang et al. 2008), and from 7.2
to 11.0% at chronic stages (4 mo post-stroke) (Page et al.
2012). In the case of CAHAI, MCID thresholds have been
established above 7% of the scale range (6.3 points) for “stable
patients” within the first year post-stroke (Barreca et al. 2005).
If the reduction of the sensitivity to treatment revealed by our
analysis exists and extends beyond 12 mo post-stroke, these
MCID estimates could be better described as a continuous
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Fig. 2. A: averaged normalized improvement rates per week after the Rehabilitation Gaming System (RGS)-based treatment and at follow-up (FU) for Upper
Extremity section of the Fugl-Meyer scale (UE-FM; top) and Chedoke Arm and Hand Activity Inventory (CAHAI) scales (bottom) by patient’s chronicity at the
time of the evaluation. The number of observations is indicated within or above each bar. *P  0.05, **P  0.01. B: comparison of the RGS, occupational therapy
(OT), and FU measures of normalized improvement rates per week for UE-FM (top) and CAHAI (bottom) scales, by patient’s chronicity at the time of the
evaluation. Solid lines indicate the average estimates based on the Whittaker smoothing algorithm (Eilers 2003). Vertical dashed lines indicate the limits of the
3 chronicity categories.
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chronic and early chronic patients. Future studies should ex-
plore this relationship to delineate more accurate MCID thresh-
olds.
It is important to note that the uncovered gradient of
sensitivity to therapy may not be specific to VR-based
interventions. However, due to the low number of chronic
patients in the OT group, we could not perform a bootstrap-
ping analysis in this sample, and we were thus not able to
evaluate the limits of the critical window in these patients.
Therefore, the generalization of our findings to therapies
based on different rehabilitation methods (e.g., Constraint-
Induced Movement Therapy) needs to be investigated. The
factors determining the duration of this critical window and
the decay rate of the patient’s responsiveness to treatment
deserve further investigation.
Our results suggest that, as during ontogenesis, the reac-
quisition of function after stroke might have to be seen as a
process that must satisfy distinct dependencies. Multiple
sensitive periods for the acquisition of motor and cognitive
function may be structured according to specific dependen-
cies. For instance, in postnatal stages, the development of
neural pathways for sensory processing precedes those of
language and motor functioning (Hensch 2005). Based on
our results, we speculate that the temporal structure of
recovery post-stroke may also comprise such a cascade of
domain-specific stages or critical periods. Clinical protocols
for rehabilitation should be evaluated in this new context.
Conclusion. We have investigated the distinct dynamics of
post-stroke recovery and the sensitivity to treatment. By
unifying results from 11 rehabilitation pilot studies, we
observed improvement in function over at all stages post-
stroke. This effect displayed a specific gradient of recovery
that faded out exponentially and reached asymptotic levels
after one year and a half post-stroke. These findings call for
an urgent scientific effort to reassess the critical window for
recovery and highlight the need for both providing early
therapy and extending it to patients in the chronic stages
post-stroke.
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Data set D1, “PatientsDemographicsAndClinicalScreening.xlxl,” con-
tains demographical data and clinical screening information (age, gender,





















Fig. 3. Spearman correlation coefficients of
recovery scores captured by the Upper Ex-
tremity section of the Fugl-Meyer scale (UE-
FM), Chedoke Arm and Hand Activity In-
ventory (CAHAI), and Barthel Index (BI),
for each chronicity quartile. Q1 (2–39 days),
Q2 (39–430 days), Q3 (439–1,198 days),
and Q4 (1,198–5,844 days). Dashed hori-
zontal lines indicate significance thresholds.
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dominance, presence of aphasia, days after stroke). Data set D2, “Clini-
calScalesAll.csv,” contains recovery scores from 219 hemiparetic stroke
patients evaluated using the Upper Extremity section of the Fugl-Meyer,
CAHAI, and BI clinical scales at multiple time points (baseline, end of the
treatment, and follow-up periods).
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